Vantus Wealth’s AstraZeneca AZN Stock Holding History

Vantus Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$385K	Buy	+2,032	New	+$382K	0.21%	136
2025 Q4	$282K	Buy	+1,534	New	+$269K	0.21%	152

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vantus Wealth's AZN Position: Q2 2026 in Review

Vantus Wealth opened a new position in AstraZeneca (AZN) in Q2 2026: 2,032 shares worth $385K. The stake represents 0.21% of the portfolio and ranks #136 among its holdings. This is a return to the name: Vantus Wealth previously reported a position in AZN as recently as Q4 2025.

Vantus Wealth first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Vantus Wealth held 2,032 shares of AstraZeneca worth $385K as of Q2 2026.
AstraZeneca was a new Vantus Wealth position in Q2 2026.
AstraZeneca made up 0.21% of Vantus Wealth's portfolio in Q2 2026, its #136 holding.
Vantus Wealth first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vantus Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.